FDA nod for Aurobindo’s Sildenafil injection

The US health regulator has approved Aurobindo Pharma’s Sildenafil injection, used for treating pulmonary arterial hypertension

id-100211390

Sildenafil is a generic version of Pfizer's Revatio injection

Aurobindo Pharma has announced that it has received approval from the US Food and Drug Administration ( US FDA) to manufacture and market Sildenafil injection.

Sildenafil injection is a generic version of Pfizer's Revatio injection.

The injection is indicated for the treatment of adult patients with pulmonary arterial hypertension who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.

 

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X